Role of MRI in diagnosing the primary site of origin in indeterminate cases of uterocervical carcinomas: a systematic review and meta-analysis
- 1 January 2022
- journal article
- review article
- Published by Oxford University Press (OUP) in The British Journal of Radiology
- Vol. 95 (1129), 20210428
- https://doi.org/10.1259/bjr.20210428
Abstract
To perform a literature review assessing role of MRI in predicting origin of indeterminate uterocervical carcinomas with emphasis on sequences and imaging parameters. Electronic literature search of PubMed was performed from its inception until May 2020 and PICO model used for study selection; population was female patients with known/clinical suspicion of uterocervical cancer, intervention was MRI, comparison was by histopathology and outcome was differentiation between primary endometrial and cervical cancers. Eight out of 9 reviewed articles reinforced role of MRI in uterocervical primary determination. T2 and Dynamic contrast were the most popular sequences determining tumor location, morphology, enhancement, and invasion patterns. Role of DWI and MR spectroscopy has been evaluated by even fewer studies with significant differences found in both apparent diffusion coefficient values and metabolite spectra. The four studies eligible for meta-analysis showed a pooled sensitivity of 88.4% (95% confidence interval 70.6 to 96.1%) and a pooled specificity of 39.5% (95% confidence interval 4.2 to 90.6%). MRI plays a pivotal role in uterocervical primary determination with both conventional and newer sequences assessing important morphometric and functional parameters. Socioeconomic impact of both primaries, different management guidelines and paucity of existing studies warrants further research. Prospective multicenter trials will help bridge this gap. Meanwhile, individual patient database meta-analysis can help corroborate existing data. MRI with its classical and functional sequences helps in differentiation of the uterine ‘cancer gray zone’ which is imperative as both primary endometrial and cervical tumors have different management protocols.This publication has 31 references indexed in Scilit:
- Dynamic contrast-enhanced MRI in endometrial carcinoma identifies patients at increased risk of recurrenceEuropean Radiology, 2013
- Diffusion-Weighted Magnetic Resonance Imaging to Detect Synchronous Uterine Endometrial and Endocervical AdenocarcinomaRare Tumors, 2012
- Measurement of the minimum apparent diffusion coefficient (ADCmin) of the primary tumor and CA125 are predictive of disease recurrence for patients with endometrial cancerGynecologic Oncology, 2012
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011
- Impact of MRI in the management and staging of cancer of the uterine cervixActa Oncologica, 2010
- Adenocarcinoma: A unique cervical cancerGynecologic Oncology, 2010
- Predicting Control of Primary Tumor and Survival by DCE MRI During Early Therapy in Cervical CancerInvestigative Radiology, 2009
- Management of cervical cancerEuropean Journal of Surgical Oncology, 2006
- Synchronous Endometrial and Cervical Tumors in a 26-Year-Old Nullipara: Diagnostic Modalities UpdatedGynecologic and Obstetric Investigation, 2005
- p16 Immunoreactivity May Assist in the Distinction Between Endometrial and Endocervical AdenocarcinomaInternational Journal of Gynecological Pathology, 2003